Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous blood versus corticosteroid injection versus brace for tennis elbow
IRCT20180422039382N2Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2018
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous blood in Lateral Epicondylitis (LET) (3 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Preferred treatment based on pain and function. Started Jul 2018; status: completed.
02
Drugs
autologous blood
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on IRCT20180422039382N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180422039382N2.